Companies Developing Cures

Discussion in 'Research News' started by Samir, May 18, 2017.

Thread Status:
Not open for further replies.
    1. Samir
      Obedient

      Samir Manager Staff Benefactor

      Location:
      Sweden
      Tinnitus Since:
      12/2016
      Cause of Tinnitus:
      Accoustic trauma
      cochlear-pro-logo.png
      cochlear-pro.png

      This thread is no longer being updated. To see the most up to date list of companies, please go to the Cochlear Pro website.

      hr-line.png

      This is a list of biotech companies developing cures for inner ear damage and disorders (hearing and balance).

      With reservation for errors, such as name of the CEO or the name of the product and target indication.

      CH: Auris Medical
      http://www.aurismedical.com/
      Founded in 2003
      CEO: Thomas Meyer (Ph.D.)
      AM-101, Acute/Post-acute inner ear tinnitus
      AM-111, ASNHL (sudden deafness)
      AM-125, Meniere's disease & Vestibular vertigo
      AM-102, Tinnitus
      DE: Böhringer Ingelheim
      http://www.boehringer-ingelheim.com/
      Founded in 1885
      CEO: Andreas Barner (Prof.)
      Regeneration of hair cells from inner ear stem cells
      DE: Acousia Therapeutics
      http://www.acousia.com/
      Founded in 2012
      CEO: Hubert Löwenheim (MD, Ph.D, Prof.)
      Prevention and treatment of hearing loss.
      Discuss it here: Acousia thread
      DE: AudioCure Pharma
      http://audiocure.de/
      Founded in 2010
      CEO: Hans Rommelspacher (Ph.D, Prof.)
      AC-002, Increase of key growth factors for neuronal repair
      AC-002, Anti-oxidant action (decrease of reactive oxygen species)
      AC-002, Protection of cells from cisplatin-induced cell death
      ES: Spiral Therapeutics
      http://spiraltx.com/
      Founded in 2016
      CEO: Hugo Peris
      Therapies targeting inner ear disorders.
      FR: Affichem
      http://www.affichem.com/
      Founded in 2002
      CEO, US: Jennifer Seibert (MBA, MSc.)
      CEO, FR: Stéphane Silvente (MS, MBA)
      AF243, a drug to restore hearing.
      FR: Sensorion Pharma
      http://www.sensorion-pharma.com/en/
      Founded in 2009
      CEO: Laurent Nguyen (MD)
      (SR1001, Neurology of the inner ear)
      SENS-111, Vertigo
      SENS-218, Vestibular lesions
      SENS-300, Drug-induced ototoxicity
      SENS-401, Sudden Sensorineural Hearing Loss
      NL: Audion Therapeutics
      http://www.audiontherapeutics.com/
      Founded in 2009
      CEO: Rolf Jan Rutten
      Hearing loss regeneration & drug delivery methods.
      UK: Autifony Therapeutics
      http://www.autifonytherapeutics.com/
      Founded in 2011
      CEO: Charles Large (Ph.D.)
      AUT00063, Age-related hearing loss & subjective tinnitus
      US: Inception3/Roche
      http://www.inceptionsci.com/
      Founded in 2011
      CEO: Peppi Prasit (Ph.D.)
      Inception 3, Sensorineural hearing loss
      US: SciFluor Life
      http://www.scifluor.com/
      Founded in 2011
      CEO: Omar Amirana (M.D.)
      SF0034, treating epilepsy and tinnitus
      US: Knopp Biosciences
      http://knoppbio.com/
      Founded in 2004
      CEO: Michael E. Bozik (M.D.)
      Treating epilepsy and tinnitus
      US: Frequency Therapeutics
      http://www.frequencytx.com/
      Founded in 2015
      CEO: David Lucchino
      Noise induced hearing loss
      Discuss it here: Frequency thread
      US: GenVec/Novartis
      http://www.genvec.com/
      Founded in 1992
      CEO: Douglas J. Swirsky (CPA, CFA)
      CGF-166, Hearing loss and vestibular dysfunction
      US: Otonomy
      http://www.otonomy.com/
      Founded in 2008
      CEO: David A. Weber (Ph.D)
      OTO-104, Meniere's disease
      OTO-201, Acute otitis media with tubes
      OTO-311, Tinnitus
      OTO-4XX, Sensorineural hearing loss
      Discuss it here: Otonomy thread
      US: Quark Pharma
      http://quarkpharma.com/
      Founded in 1994
      CEO: Daniel Zurr (Ph.D.)
      QP-HL1 Otoprotection
      QP-HL2 Meniere's disease
      QP-HL3 Hearing regeneration
      US: Sound Pharmaceuticals
      http://soundpharma.com/
      Founded in 2001
      CEO: Eric D. Lynch (Ph.D.)
      SPI-1005, Acute NIHL Mild to Moderate, Meniere’s Disease
      SPI-3005, Chemotherapy-Induced Ototoxicity, Aminoglycoside-Induced Ototoxicity
      SPI-5557, Severe to Profoundly Impaired hearing, regeneration
      US: Oricula Therapeutics
      http://www.oricularx.com/
      Founded in 2013
      CEO: Malcolm Gleser (MD, Ph.D.)
      ORC-0001, protect hair cells from aminoglycosides
      US: Decibel Therapeutics
      https://decibeltx.com/
      Founded in 2015
      CEO: Steven H. Holtzman (Ph.D.)
      Protect, repair and restore hearing
      US: AGTC (in preparation)
      https://www.agtc.com/
      Founded in 1999
      CEO: Susan B. Washer (MBA, BS)
      Exploring genetic defects in cells in the inner ear
      US: Otologic Pharmaceutics
      http://otologicpharmaceutics.com/
      Founded in 2009
      CEO: Clayton I. Duncan (MBA, MA)
      NHPN-1010, Otoprotectant, prevent and treat acute hearing loss, prevent permanent hearing disorders, acute noise induced hearing loss, treat tinnitus, vestibular injury and traumatic brain injury associated hearing disorders
      US: Fennec Pharmaceuticals
      http://fennecpharma.com/
      Founded in 1996
      CEO: Rostislav Raykov (BSBA)
      Sodium Thiosulfate (STS), Reducing Ototoxicity in Patients Receiving Cisplatin Chemotherapy
      US: Anida Pharma
      http://www.anidapharma.com/
      CEO: Per Gjorstrup (M.D. & Ph.D.)
      Neuroprotectin D1 (NPD1), Drug-induced hearing loss
       
      Last edited: Jan 3, 2018
      • Like Like x 12
      • Informative Informative x 4
      • Hug Hug x 1
Loading...

Share This Page

Thread Status:
Not open for further replies.